Status:
UNKNOWN
Education With Inhalers in Patients With COPD Exacerbation
Lead Sponsor:
Universidad de Granada
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a public health problem with great morbidity. The main therapeutic strategy is inhalers. The objective of this study is to determine the efficacy of an ...
Detailed Description
The importance of this pathology lies not only in its high prevalence, which is expected to increase due to the aging of society but also in its high mortality. In Europe, it is estimated that 50% of ...
Eligibility Criteria
Inclusion
- Inclusion criteria were to be clinically diagnosed of exacerbation of COPD, to possess pharmacological treatment in the form of inhalers.
Exclusion
- Exclusion criteria were inability to provide informed consent, presence of psychiatric or cognitive disorders, neurological disorders, organ failure, cancer or inability to cooperate. Patients who had experienced an exacerbation of prior COPD in less than one month were excluded.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2018
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03337958
Start Date
December 1 2017
End Date
July 1 2018
Last Update
July 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Physical Therapy
Granada, Spain, 18071